Kynam Capital Management LP 13D and 13G filings for Concert Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 09:25 am Unchanged | 2022-12-30 | 13G | Concert Pharmaceuticals, Inc. CNCE | Kynam Capital Management LP | 4,420,349 9.200% | 0 (Unchanged) | Filing |
| 2023-02-10 3:51 pm Purchase | 2022-12-30 | 13G | Concert Pharmaceuticals, Inc. CNCE | Kynam Capital Management LP | 4,420,349 9.200% | 4,420,349 (New Position) | Filing |